Larimar Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.13

+0.04 (+0.98%)

As of May 16, 2:00 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +463.4% upside

Low Target $16.60

Average Target $23.27

High Target $30.48

Current Price $4.13

Current
$4.13

Target
$23.27

$16.60 $23.27 avg $30.48

Scenario Analysis

Bear Case

$16.60

301.9%

Low target

Base Case

$23.27

+463.4%

Avg target

Bull Case

$30.48

+638.0%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$6.42

-35.7% from high

52-Week Low

$1.73

+138.7% from low

Target vs 52W High

$23.27

+262.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%